Test Compendium
Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 251 - 275 of 352
WT-1
Immunohistochemistry (IHC)WT-1 Alternative Name Wilms Tumor Methodology Immunohistochemistry (IHC) Test Description Probes/Genes WT1 IHC Disease Wilms tumor, mesothelioma, fallopian tube and ovarian serous carcinoma, metanephric
MMR Panel by IHC (MLH1, MSH2, MSH6, PMS2)
Immunohistochemistry (IHC)MMR Panel by IHC (MLH1, MSH2, MSH6, PMS2) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MLH1, MSH2, MSH6, PMS2 Disease Lynch syndrome, carcinomas of the rectum, colon, small intestine
Leukemia/Lymphoma Screen
Flow cytometryLeukemia/Lymphoma Screen Methodology Flow cytometry Test Description Probes/Genes CD3, CD4, CD5, CD8, CD14, CD19, CD20, CD33, CD34, CD38, CD45, CD56, CD117, Kappa, Lambda Disease Anemia, leukopenia, leukocytosis,
Myelodysplastic syndrome (MDS) Flow Panel
Flow cytometryMyelodysplastic syndrome (MDS) Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11b, CD13, CD14, CD15, CD16, CD19, CD33, CD34, CD36, CD38, CD45,
Acute leukemia Flow Panel
Flow cytometryAcute leukemia Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, cCD3, sCD3, CD4, CD5, CD7, CD8, CD10, CD11b, sCD13, cCD13, CD14, CD15, CD16, CD19, cCD22, CD33, CD34, CD36, CD38,
B-cell Acute Lymphoblastic Leukemia (B-ALL) Flow Panel
Flow cytometryB-cell Acute Lymphoblastic Leukemia (B-ALL) Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, cCD3, sCD3, CD4, CD5, CD7, CD8, CD10, CD11b, sCD13, cCD13, CD14, CD15, CD16, CD19, CD20,
T-cell Acute Lymphoblastic Leukemia (T-ALL) Flow Panel
Flow cytometryT-cell Acute Lymphoblastic Leukemia (T-ALL) Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD1a, CD2, cCD3, sCD3, CD4, CD5, CD7, CD8, CD10, CD11b, sCD13, cCD13, CD14, CD15, CD16, CD19,
Lymphoproliferative Disorder (LPD) FLow Panel
Flow cytometryLymphoproliferative Disorder (LPD) FLow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11c, CD16, CD19, CD20, CD23, CD38, CD45, CD56, CD57, Kappa,
Chronic Lymphocytic Leukemia (CLL) Flow Panel
Flow cytometryChronic Lymphocytic Leukemia (CLL) Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11c, CD16, CD19, CD20, CD23, CD38, CD43, CD45, CD49d, CD56,
Hairy Cell Leukemia (HCL) Flow Panel
Flow cytometryHairy Cell Leukemia (HCL) Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11c, CD16, CD19, CD20, CD23, CD25, CD38, CD45, CD56, CD57, CD103, CD123,
Diffuse Large B-Cell Lymphoma / Follicular Lymphoma Flow Panel
Flow cytometryDiffuse Large B-Cell Lymphoma / Follicular Lymphoma Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11c, CD16, CD19, CD20, CD23, CD25, CD38, CD45,
T-cell Lymphoproliferative Disorder Flow Panel
Flow cytometryT-cell Lymphoproliferative Disorder Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11c, CD16, CD19, CD20, CD23, CD25, CD26, CD30, CD38, CD45,
Myeloma Flow Panel
Flow cytometryMyeloma Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD3, CD4, CD8, CD19, CD20, CD27, CD28, CD38, CD45, CD56, CD81, CD117, CD138, IgA, IgG, IgM, cKappa, cLambda Disease Anemia,
Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma Flow Panel
Flow cytometryWaldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma Flow Panel Methodology Flow cytometry Test Description Probes/Genes CD3, CD4, CD5, CD8, CD14, CD19, CD20, CD27, CD28, CD33, CD34, CD38, CD45,
Myeloma MRD Flow Panel
Flow cytometryMyeloma MRD Flow Panel Alternative Name Myeloma Measurable/Minimal Residual Disease Methodology Flow cytometry Test Description Probes/Genes CD19, CD27, CD45, CD56, CD81, CD117, CD138, cKappa, cLambda,
Paroxysmal nocturnal hemoglobinuria (PNH) - peripheral blood panel
Flow cytometryParoxysmal nocturnal hemoglobinuria (PNH) - peripheral blood panel Methodology Flow cytometry Test Description Probes/Genes CD14, CD15, CD24, CD45, CD64, FLAER Alexa-488, CD59, CD235a Disease Paroxysmal
Paroxysmal nocturnal hemoglobinuria (PNH) - bone marrow aspirate panel
Flow cytometryParoxysmal nocturnal hemoglobinuria (PNH) - bone marrow aspirate panel Methodology Flow cytometry Test Description Probes/Genes CD59, CD235a Disease Paroxysmal nocturnal hemoglobinuria (PNH)Paroxysmal
Oncoswift® Frontier
Oncoswift® Frontier Test Description Probes/Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR1, FGFR2,
LymphoSight™
LymphoSight™ Test Description Probes/Genes IHC/CISH ALK1, BCL-1, BCL-2, BCL-6, BRAF, Bob1, CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD20, CD21,
FOLR-1
Immunohistochemistry (IHC)FOLR-1 Alternative Name folate receptor alpha Methodology Immunohistochemistry (IHC) Test Description Disease epithelial ovarian cancer (EOC)FOLR1 (FOLR1-2.1) RxDx Assay is the first and only immunohistochemistry
PRAME
Immunohistochemistry (IHC)PRAME Alternative Name PReferentially expressed Antigen in MElanoma Methodology Immunohistochemistry (IHC) Test Description Disease Differential diagnoses of benign versus malignant melanocytic lesions,
HPV-HR
In Situ Hybridization (ISH)HPV-HR Alternative Name Human papillomavirus (HPV)- High Risk , HPV RNA ISH 16/18, HPV RNA ISH High Risk Cocktail Methodology In Situ Hybridization (ISH) Test Description Disease Types of HPV can cause
HPV-LR
In Situ Hybridization (ISH)HPV-LR Alternative Name Human papillomavirus (HPV)- Low Risk , HPV RNA ISH Low Risk Cocktail Methodology In Situ Hybridization (ISH) Test Description Disease Low risk, or non-oncogenic, types of the virus
PDL 28-8
Immunohistochemistry (IHC)PDL 28-8 Alternative Name PD-L1 28-8 (OPDIVO®) Methodology Immunohistochemistry (IHC) Test Description Disease Gastric/GEJ/Esophageal AdenocarcinomaPD-L1 IHC 28-8 pharmDx is a qualitative immunohistochemical
PDL SP263
Immunohistochemistry (IHC)PDL SP263 Alternative Name IMFINZI Methodology Immunohistochemistry (IHC) Test Description Disease non-small cell lung cancer (NSCLC)PD-L1 (SP263) assay is a qualitative immunohistochemical assay using
